Related Experiment Video
Updated: Jun 26, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation
Athanasios Papakyriakou1, Dionisios Vourloumis, Fotini Tzortzatou-Stathopoulou
1Institute of Physical Chemistry, NCSR 'Demokritos', Athens, Greece.
Abstract:
The epidermal growth factor receptor (EGFR) has been the focus of intensive studies because of its importance in cancer research. Thus, a broader understanding of the molecular mechanism of activation of the EGFR kinase will have profound significance for the development of novel therapeutics. Numerous crystal structures of EGFR kinase, including the structure of the activating-kinase dimer, have provided snapshots of the specific pathway. Herein, we performed unrestrained-, as well as targeted-molecular dynamics simulations based on these data, to gain further insight into the conformational changes responsible for activation. Comparison of the monomer- versus activating-EGFR-dimer simulations indicates that the dimerization is stabilizing structural elements associated with the activated state and predicts new salt-bridge interactions involving activation-loop residues that may also be associated with that state. Targeted molecular dynamics simulations of the inactive-to-active EGFR transition, as well as the reverse pathway, confirm the formation of conserved structural features of functional importance for the activity or stabilization of either conformation. Interestingly, simulations of the L834R mutant, which is associated with cancer, suggest that the structural basis of the activation induced by that mutation might be the ability of the mutated R834 residue to consecutively form salt bridges with neighboring acidic residues and cause destabilization of a hydrophobic cluster in the inactive state.
Insights
Understanding epidermal growth factor receptor (EGFR) activation is key for cancer therapeutics. Molecular dynamics simulations reveal how EGFR dimerization stabilizes its active form and how mutations drive cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Biology
Background:
- Epidermal growth factor receptor (EGFR) is crucial in cancer research.
- Understanding EGFR kinase activation mechanisms is vital for developing new cancer therapies.
Purpose of the Study:
- To investigate the conformational changes in EGFR during activation using molecular dynamics.
- To elucidate the structural basis of EGFR activation and the impact of cancer-associated mutations.
Main Methods:
- Unrestrained and targeted molecular dynamics simulations were performed.
- Simulations utilized existing crystal structures of EGFR kinase, including the active dimer.
Main Results:
- EGFR dimerization stabilizes key structural elements of the active state.
- New salt-bridge interactions involving activation-loop residues were predicted.
- Simulations confirmed conserved structural features during the inactive-to-active EGFR transition.
- The L834R cancer mutation's structural basis for activation was identified, involving salt bridges and hydrophobic cluster destabilization.
Conclusions:
- EGFR dimerization plays a significant role in stabilizing the active conformation.
- Specific salt bridges and hydrophobic interactions are critical for EGFR conformational states.
- The L834R mutation promotes EGFR activation through distinct structural mechanisms, offering therapeutic insights.
Related Concept Videos
Receptor Tyrosine Kinases
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Mitogens and the Cell Cycle
Amplifying Signals via Enzymatic Cascade
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
